IndusInd Bank, SBI, HCL Tech, ITC and Sun Pharma were among the top losers on NSE in today's trade.

Bajaj Finance, Bajaj Finserv, Adani Ports SEZ, Divis Labs and UPL were among the top losers on NSE in today's trade.

The stock hit a 52-week high of Rs 2,316.60 in early October, a rally of 480 per cent over its issue price to Rs 400.

Among the stock-specific action, Nureca, Cybertech Systems and India Glycols hit their upper circuits of 20 per cent each. Manaksia Aluminu...

Hornbill Orchid India Fund bought 195,766 shares of Nureca at Rs. 1,550 apiece through bulk deal on the BSE.

Out of the 30 companies, 13 have delivered over 100 per cent return since listing. The list featured Route Mobiles, Happiest Minds and Tech...

The second wave of the pandemic has increased demand for products like oximeters, thermometers, BP monitors, nebulisers and multivitamins, ...

Grey market trends suggest the stock indeed may see decent listing gains, but that may not be enough for it to replicate Nureca's performan...

At the issue price, the stock was priced at a P/E of 62.55 times on its earnings per share of Rs 6.40.

India’s drug regulator has not cleared the application of Dr Reddy’s Laboratories seeking approval to market the Sputnik V Covid-19 vaccine...

The issue, which was sold from February 15 to February 17, had received a solid 166.65 times retail bids.

At the upper price band, Nureca IPO is priced at pre-issue PE of 46.91 times its FY20 EPS of Rs 8.53.

Employees of the company are being offered a discount of Rs 20 per share.

The IPO, which is being sold in a Rs 396-400 price band, received bids for 2,07,03,200 shares, which was 14.8 times the issue size of 14,01...

Prospective retail investors can bid for a minimum of one lot of 35 shares, and a maximum of 14 lots, or 490 shares.

The IPO comprises issuance of equity shares worth Rs 100 crore, a draft red herring prospectus filed with Securities and Exchange Board of ...

Proceeds of the issue will be used for funding incremental working capital requirements of the company and general corporate purposes.